Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Journal of the American College of Cardiology
|
March 1, 1996
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial
L K Newby, R M Califf, A Guerci, et al.
American Heart Journal
|
June 1, 1997
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators
R M Califf, L H Woodlief, F E Harrell, et al.
JAMA
|
March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators
W D Weaver, H D White, R G Wilcox, et al.
Leukemia
|
April 24, 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes
E Wattel, E Solary, X Leleu, et al.
Leukemia Research
|
August 2, 2011
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS
S Park, R Sapena, C Kelaidi, et al.
Blood
|
October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group
E Wattel, A Guerci, B Hecquet, et al.
Journal of the American College of Cardiology
|
February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators
A B Greenbaum, R A Harrington, M P Hudson, et al.
Leukemia
|
November 9, 2011
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
F Damm, F Thol, O Kosmider, et al.
Leukemia
|
March 17, 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)
C Kelaidi, L Ades, S Chevret, et al.
Leukemia & Lymphoma
|
July 16, 2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy
X Thomas, Qh Le, S de Botton, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Journal of the American College of Cardiology
|
March 1, 1996
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial
L K Newby, R M Califf, A Guerci, et al.
American Heart Journal
|
June 1, 1997
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators
R M Califf, L H Woodlief, F E Harrell, et al.
JAMA
|
March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators
W D Weaver, H D White, R G Wilcox, et al.
Leukemia
|
April 24, 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes
E Wattel, E Solary, X Leleu, et al.
Leukemia Research
|
August 2, 2011
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS
S Park, R Sapena, C Kelaidi, et al.
Blood
|
October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group
E Wattel, A Guerci, B Hecquet, et al.
Journal of the American College of Cardiology
|
February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators
A B Greenbaum, R A Harrington, M P Hudson, et al.
Leukemia
|
November 9, 2011
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
F Damm, F Thol, O Kosmider, et al.
Leukemia
|
March 17, 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)
C Kelaidi, L Ades, S Chevret, et al.
Leukemia & Lymphoma
|
July 16, 2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy
X Thomas, Qh Le, S de Botton, et al.
Page
of 8